Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.
Created by
Related Presenters
Assistant Professor of Oncology
Breast and Early Phase Clinical Trials, Department of Medicine
Shipra Gandhi, MD is an Assistant professor of oncology at the Roswell Park Comprehensive Cancer Center. She completed her fellowship in hematology and oncology at Roswell Park Comprehensive Cancer Center, Buffalo, NY and recieved her board certification
BROADCASTMED